HRT Financial’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-103,651
| Closed | -$1.67M | – | 3113 |
|
|
2023
Q4 | $1.67M | Buy |
103,651
+46,153
| +80% | +$744K | 0.01% | 692 |
|
|
2023
Q3 | $731K | Buy |
57,498
+41,426
| +258% | +$527K | 0.01% | 1068 |
|
|
2023
Q2 | $226K | Buy |
+16,072
| New | +$226K | ﹤0.01% | 1607 |
|
|
2023
Q1 | – | Sell |
-89,970
| Closed | -$1.47M | – | 3166 |
|
|
2022
Q4 | $1.47M | Buy |
89,970
+2,242
| +3% | +$36.7K | 0.02% | 689 |
|
|
2022
Q3 | $1.62M | Buy |
87,728
+72,254
| +467% | +$1.34M | 0.02% | 655 |
|
|
2022
Q2 | $203K | Sell |
15,474
-227,524
| -94% | -$2.98M | ﹤0.01% | 2170 |
|
|
2022
Q1 | $2.25M | Buy |
+242,998
| New | +$2.25M | 0.02% | 539 |
|
|
2021
Q4 | – | Sell |
-19,628
| Closed | -$666K | – | 3962 |
|
|
2021
Q3 | $666K | Buy |
+19,628
| New | +$666K | ﹤0.01% | 1569 |
|
|
2021
Q1 | – | Sell |
-3,815
| Closed | -$217K | – | 3055 |
|
|
2020
Q4 | $217K | Buy |
+3,815
| New | +$217K | ﹤0.01% | 1396 |
|
|
2019
Q4 | – | Sell |
-14,415
| Closed | -$489K | – | 1656 |
|
|
2019
Q3 | $489K | Buy |
+14,415
| New | +$489K | 0.02% | 602 |
|